name: david h. barad, md, ms - center for human ...community hosp at dobbs ferry 128 ashford ave...

CV David Barad

Last updated: 10/9/2019

CURRICULUM VITAE

Name: David H. Barad, MD, MS

Date of birth: March 29, 1950

Citizenship: United States of America

Address: Office: Center for Human Reproduction 21 East 69th Street New York, NY 10021 Telephone ........................................................ (212) 994-4400 Fax: .................................................................. (212) 994-4499 Email ........................................................ [email protected]

CV David Barad

Education: School Location Major Degree Date Rutgers New Brunswick,

NJ

Biology BA June 1972

Boston University Graduate School

Boston, Mass

Comparative Endocrinology /Biology

MA June 1974

Rutgers Medical School (Robert Wood Johnson)

Piscataway, NJ

Medicine MD June 2, 1978

Albert Einstein College of Medicine

Bronx, NY Clinical Research Training Program

MS June 4, 2003

Master Theses:

Masters of Arts in Comparitive Endocrinology – Boston University

Circulating plasma estrogen levels in the female turtle chrysemys picta during its annual reproductive cycle and following gonadotropin treatment - 1975.

Masters of Science in Clinical Research – Albert Einstein College of Medicine 2003

Association of hypertension and history of hysterectomy among menopausal women. – 2003

Post Graduate Clinical education: Hospital Location Program PG year Dates Metropolitan Hospital New York, New

York

Obstetrics & Gynecology Internship

PGY 1 (6mos)

7/1/78 - 12/31/78

Sloane Hospital for Women/ Columbia Presbyterian Medical Center

New York, New York

Obstetrics & Gynecology Internship

PGY 1 (6mos)

1/1/79 -6/30/79

Sloane Hospital for Women/ Columbia Presbyterian Medical Center

New York, New York

Obstetrics & Gynecology Residency

PGY 2 PGY 3 PGY 4 (Chief)

7/1/79 -6/30/82

Brigham and Women's Hospital

75 Francis Street Boston, Massachusetts

Fellow in Obstetrics & Gynecology (Reproductive Endocrinology)

PGY 5 PGY 6

7/1/82 - 6/30/84

CV David Barad

Professional employment and Hospital appointments:

Professional employment Position

Department Dates

Director of Assisted Reproduction Center for Human Reproduction, NYC

7/03 - Present

Clinical Associate Professor Obstetrics, Gynecology and Women’s Health Albert Einstein College of Medicine Bronx, New York

7/1/11 - Present

Associate Clinical Professor Epidemiology and Social Medicine Albert Einstein College of Medicine Bronx, New York

5/05 – 6/30/11

Associate Clinical Professor Obstetrics, Gynecology and Women’s Health Albert Einstein College of Medicine Bronx, New York

4/01 – 6/30/11

Director of Gynecology

Community Hospital at Dobbs Ferry Dobbs Ferry, New York 10522

1998- 4/01

Associate Professor Obstetrics, Gynecology and Women’s Health Albert Einstein College of Medicine Bronx, New York

7/1/90 – 4/01

Director Division of Reproductive Endocrinology And Infertility Department of Obstetrics, Gynecology & Women’s Health Albert Einstein College of Medicine Bronx, New York

12/85 – 9/98

Director Division of Reproductive Endocrinology and Infertility Department of Obstetrics, Gynecology & Women’s Health Montefiore Medical Center Bronx, New York

12/85- 4/01

Acting Director Division of Reproductive Endocrinology And Infertility Department of Obstetrics & Gynecology Albert Einstein College of Medicine Bronx, New York

5/85 - 12/85

Head of Reproductive Endocrinology

Bronx Municipal Hospital Center Bronx, New York

7/1/84 – 7/98

Assistant Professor Obstetrics & Gynecology 7/1/84 - 7/1/90

CV David Barad

Albert Einstein College of Medicine Bronx, New York

Clinical Instructor Obstetrics & Gynecology Harvard Medical School Boston, Massachusetts

7/1/82 - 6/30/84

CV David Barad

Hospital Appointments Institution Address Depart./

Service Staff

Category Dates

St. Luke’s-Roosevelt Hospital Center

555 W. 57th Street, New York, NY 10019

OB/GYN Attending May 2004 - Present

Community Hosp at Dobbs Ferry

128 Ashford Ave Dobbs Ferry, NY 10522-1924

Gynecology Director 1995 - 2001

Montefiore Medical Center 1825 Eastchester Rd Bronx, NY 10461 Obs & Gyn Attending 1990 – 2001

Bronx Municipal Hospital Center

Pelham Parkway South & Eastchester Rd, Bronx, NY

Obs & Gyn Attending 1984 - 1989

Brigham and Women’s Hospital

75 Francis St Boston, MA 02115 Obs & Gyn Instructor 7/82 – 5/84

Board Certification American Board of Obstetrics and Gynecology

Board Certified 1985

American Board of Obstetrics and Gynecology

Re-certification 2008

Reproductive Endocrinology Written Exam Jun 1986 American Board of Obstetrics and Gynecology

Board Certified Reproductive Endocrinology Dec 1988

American Board of Obstetrics and Gynecology

Re-certification 2008

Accreditation Council for Gynecologic Endoscopy

Certified in Operative Laparoscopy and Operative Hysteroscopy

1996

CV David Barad

Professional Society Memberships American Society of Reproductive Medicine

ASRM – Reproductive Biology Special Interest Group

American Medical Association

New York State Medical Association

American Association of Gynecological Laparoscopists

American College of Obstetrics & Gynecology

Society of Reproductive Endocrinologists

Society of Assisted Reproductive Technology

New York Obstetrical Society

Society of the Slone Hospital for Women

Awards and Honors Howard C. Taylor Award for Teaching Excellence

Columbia-Presbyterian Medical Center Sloane Hospital for Women - 1982 New York, New York

Residents Teaching Award Albert Einstein College of Medicine - spring 1985 Bronx, New York

Resolve of NYC Chapter Award - October 1996 Grand Hyatt, New York City American Infertility Association Award – October 1999 Grand Hyatt, New York City

CV David Barad

Other Professional Activities Ad Hoc Review: RFA-AG-94-002 "Menopause and Health in Aging Women" April 12-

13, 1994 NHLBI Special Emphasis Panel: RFP-NHLBI-HC-94-16 & 17 "Angiographic Trial in

Women" September 26-27, 1994 P&P HRT Special Interest Group – Women’s Health Initiative (1997 – present) Hormone Replacement Committee – Women’s Health Initiative (1997 – present) Hormone Trials Advisory Committee Chair – Women’s Health Initiative (2002 – present) Steering Committee – Women’s Health Initiative (2002 – present) New York State Task Force on Life and the Law – Advisory Group on Reproductive

Technologies (1999 - 2000) Consent for ART and Donor services. Co-Chair – HRT and CaD adherence and Retention Conference – Women’s Health

Initiative (1999 - 2000) Chair – HRT – Report of interval findings in the Women’s Health Initiative to

participants. – Women’s Health Initiative (2000) Co-Chair Women’s Health Initiative Clinical Trial – Closeout Working Group (1999 to

present) Vice-Chair ASRM Menopause Special Interest Group (2003) Chair ASRM Menopause Special Interest Group (2007-2008)

Advisory Boards New York City Resolve: Medical Advisory Board, 1998-1999

American Infertility Association: Medical Advisory Board, 1999- 2000

Journal Review Obstetrics and Gynecology American Journal of Obstetrics and Gynecology Fertility and Sterility Journal of Assisted Reproduction and Genetics PLoS ONE Reproductive Biomedicine Online

Editorial Board Journal of Assisted Reproduction and Genetics (205-2009) ....................

CV David Barad

NIH Funded Research

Co-Investigator- Women’s Health Initiative ......................................................................... 1994-2011

The Clinical Center of the Department of Obstetrics, Gynecology & Women’s Health of the Montefiore Medical Center/ Albert Einstein College is one of 40 clinical centers selected to conduct the WHI Clinical Trial and Observational Study and is the only one in the metropolitan New York area. The Women’s Health Initiative (WHI) is a national, multicenter study of the health of postmenopausal women and consists of several overlapping clinical trials to test interventions to prevent breast cancer, heart disease and colorectal cancer and osteoporosis. The WHI also includes an observational study to uncover disease markers and risk factors. The clinical trials are initiated to determine if hormone replacement therapy (HRT) prevents heart disease, osteoporosis and colorectal cancer. One ancillary study seeks to determine if HRT prevents Alzheimer's disease and age-associated cognitive decline. The Dietary Modification Trial seeks to determine if a low fat, high grain, fruit and vegetable eating patterns will prevent breast cancer and heart disease. The Calcium/Vitamin D supplement trial is to determine if these supplements will prevent osteoporosis and colorectal cancer. The WHI is the largest clinical trial ever funded by NIH. Nationally, 160, 000 women are participating. The WHI represents a collaborative effort of the departments of Epidemiology and Social Medicine, OBGYN-WH, and Medicine. The AECOM/ MMC Clinical Center succeeded in recruiting the goal of 4,500 community-based women within the Bronx and NY Metropolitan area.

CV David Barad

Invited Presentations

1. Cryopreservation and risk for triplet pregnancy. June 2002; Budapest, Hungary

2. "WHI: Where We Are and Where We Are Going." June 18, 2002; Wave Hill, Bronx, NY

3. What we have learned: lessons from the Women’s Health Initiative, Grand Rounds September 16, 2003, CHR New York, NY

4. What we have learned: lessons from the Women’s Health Initiative, Grand Rounds September 26, 2003, CHR Chicago, Ill.

5. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women, Department of Obstetrics and Gynecology, Salt Lake City, Utah March 26, 2003.

6. Is there still a place for surgery? Center for Human Reproduction; Post-Graduate Course. Chicago, Illinois June 2003.

7. “Infertility for Beginners: Questions and Answers” American Infertility Association, Grand Hyatt, New York, NY March 25, 2004.

8. Infertility treatment for the Primary Care Provider, Center for Human Reproduction, Postgraduate course, June 2003.

9. WHI: Estrogen plus Progestin Breast and Gynecologic Cancer, Cornell Presbyterian Medical Center, October 20, 2003.

10. Hormone treatment and Cardiovascular Disease: Are SERMs the Answer? Taiwan Society of Cardiovascular Disease Prevention and Control. 9th Nov, 2003

11. New ideas in ovulation induction. Dept of Onstetrics and Gynecology NYU Downtown May 2005

12. What happened when the hormones stopped? : after the WHI. Englewood Hospital, Englewod, NJ May 10 2005

13. Traditional Chinese Medicine and Hot Flashes. Presented to the TCM Society of New York, February 2005

14. Symptom experience after discontinuing use of estrogen plus progestin in the WHI Clinical trial. Maimonides Medical Center, Brooklyn NY, January 6, 2006

15. Managing menopausal symptoms among minority women. Symposium, “Evidence based approaches to Menopause III. SGI Toronto Canada March 24, 2006

16. Evidence based medicine (EBM): what’s next? Cannot replace clinical judgment. Controversies in Obstetrics and Gynecology. Berlin, Germany, November 4-6, 2010.

17. Preimplantation genetic screening (PGS) is an experimental tool that should be banned from routine clinical use: PGS, as currently practiced, is associated with inferior results and should not be routinely offered. Controversies in Obstetrics and Gynecology. Berlin, Germany, November 4-6, 2010.

18. Has anti-Mullerian hormone (AMH) become essential in assessing ovarian reserve?: No. Controversies in Obstetrics and Gynecology. Berlin, Germany, November 4-6, 2010.

19. Can diminished ovarian reserve be treated effectively?: Yes. Controversies in Obstetrics and Gynecology. Berlin, Germany, November 4-6, 2010.

CV David Barad

20. Trends in racial disparities in ART outcomes. UIT 2012, Budapest, Hungary, February 2012.

21. Ovarian Reserve and the Role of Anti-Mullerian Hormone. Canadian Society of Clinical Chemistry (CSCC) and the Société Québécoise de Biologie Clinique (SQBC). Québec City, June 19, 2012.

22. Ovarian reserve and Oocyte Quality. CFAS’s Annual Meeting, Ottawa, ON, September 6-9, 2012. 497.

23. Is DHEA an answer to low ovarian reserve? A 7-city lecture series organized by Sun Pharmaceuticals, LTD, Mumbai, India, May 26 – June 4, 2014.

24. Epigenetic Effects of FMR1 Expression on Ovarian Function. Grand Rounds June 23, 2015, CHR New

York, NY

Medical School Committees: ..................................................................................

Ethics Committee on Reproductive Technology -1987 - 2000

Admissions Committee of Albert Einstein College of Medicine - 1988 – 1993

Subcommittee on Clinical Sciences Curriculum -1986- 1988

Educational Planning and Policy Committee - 1986 - 1990

Department of Obstetrics and Gynecology Promotions Committee: 1992- 1998

Dean's Committee on Conflict of Interest: 1994-1996

Bibliography

A. Original Communications in Reviewed Journals: (1-54) [1-50]

1. Callard, I.P., V. Lance, A.R. Salhanick, and D. Barad. The annual ovarian cycle of Chrysemys picta: correlated changes in plasma steroids and parameters of vitellogenesis. Gen Comp Endocrinol, 1978. 35(3): p. 245-57.

2. Barad, D.H., M.L. Gimovsky, R.H. Petrie, and E.T. Bowe. Diagnosis and management of bilateral theca lutein cysts in a normal term pregnancy. Diagn Gynecol Obstet, 1981. 3(1): p. 27-30.

3. Baxi, L., E.A. Reece, and D. Barad. Hemoglobin A1c levels and variant hemoglobins. Am J Obstet Gynecol, 1984. 150(6): p. 794-5.

4. Baxi, L., D. Barad, E.A. Reece, and R. Farber. Use of glycosylated hemoglobin as a screen for macrosomia in gestational diabetes. Obstet Gynecol, 1984. 64(3): p. 347-50.

CV David Barad

5. Baxi, L., E.A. Reece, D. Barad, R. Farber, and A. Williams. Glycosylated hemoglobin (HbA1) and hemoglobinopathies in pregnancy. J Perinat Med, 1984. 12(3): p. 133-6.

6. Schneider, E.P., H.E. Fox, D. Barad, and R.S. Farber. Fluorescence polarization values of amniotic fluid collected from the vagina after rupture of the membranes. Am J Obstet Gynecol, 1985. 152(5): p. 572-3.

7. Barad, D.H., G. Bartfai, P. Barg, B.L. Cohen, and M. Feinman. Gamete intrafallopian tube transfer (GIFT): making laparoscopy more than "diagnostic". Fertil Steril, 1988. 50(6): p. 928-30.

8. Barad, D.H., K.J. Ryan, K. Elkind-Hirsch, and A. Makris. Immunoreactive substance P in the human ovary. Am J Obstet Gynecol, 1988. 159(1): p. 242-6.

9. Barad, D. and M. Feinman. GnRH Agonists and IVF--controls? Fertil Steril, 1989. 52(3): p. 518-9.

10. Feinman, M., D. Barad, I. Szigetvari, and S.G. Kaali. Availability of donated oocytes from an ambulatory sterilization program. J Reprod Med, 1989. 34(7): p. 441-3.

11. Szigetvari, I., M. Feinman, D. Barad, G. Bartfai, and S.G. Kaali. Association of previous abdominal surgery and significant adhesions in laparoscopic sterilization patients. J Reprod Med, 1989. 34(7): p. 465-6.

12. Barg, P.E., D.H. Barad, and W. Feichtinger. Ultrarapid freezing (URF) of mouse and human preembryos: a modified approach. J In Vitro Fert Embryo Transf, 1990. 7(6): p. 355-7.

13. Borgatta, L., L. Gruss, D. Barad, and S.G. Kaali. Direct trocar insertion vs. Verres needle use for laparoscopic sterilization. J Reprod Med, 1990. 35(9): p. 891-4.

14. Feichtinger, W., D. Barad, M. Feinman, and P. Barg. The use of two-component fibrin sealant for embryo transfer. Fertil Steril, 1990. 54(4): p. 733-4.

15. Kaali, S.G., G.M. Csakany, I. Szigetvari, and D.H. Barad. Updated screening protocol for abortion services. Obstet Gynecol, 1990. 76(1): p. 136-8.

16. Barad, D.H. Infertility surgery by laparotomy. Curr Opin Obstet Gynecol, 1991. 3(3): p. 398-403.

17. Borgatta, L. and D. Barad. Prolonged retention of laminaria fragments: an unusual complication of laminaria usage. Obstet Gynecol, 1991. 78(5 Pt 2): p. 988-90.

18. Borgatta, L., L. Gruss, and D. Barad. Randomized trial of local anesthetic application for the relief of postoperative pain after tubal sterilization with Fallope rings. Am J Gynecol Health, 1991. 5: p. 11-15.

19. Daiter, E., S. Pampfer, Y.G. Yeung, D. Barad, E.R. Stanley, and J.W. Pollard. Expression of colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metab, 1992. 74(4): p. 850-8.

CV David Barad

20. Kaali, S.G. and D.H. Barad. Incidence of bowel injury due to dense adhesions at the sight of direct trocar insertion. J Reprod Med, 1992. 37(7): p. 617-8.

21. Naz, R.K., D. Barad, P. Barg, K. Ahmad, and K. Bhargava. Antigenic differences in human sperm samples related to various morphological abnormalities. Arch Androl, 1992. 29(2): p. 117-26.

22. Pampfer, S., E. Daiter, D. Barad, and J.W. Pollard. Expression of the colony-stimulating factor-1 receptor (c-fms proto-oncogene product) in the human uterus and placenta. Biol Reprod, 1992. 46(1): p. 48-57.

23. Witt, B.R. and D.H. Barad. Management of endometriosis in women older than 40 years of age. Obstet Gynecol Clin North Am. Vol. 20. 1993. 349-63.

24. Kaali, S.G., D.H. Barad, and I.R. Merkatz. Comparison of visual and tactile localization of the trocar tip during abdominal entry. J Am Assoc Gynecol Laparosc, 1994. 2(1): p. 75-7.

25. Kaali, S.G. and D.H. Barad. An updated protocol for abortion surveillance with ultrasound and immediate pathology. Obstet Gynecol, 1994. 83(5 Pt 1): p. 797-8.

26. LindHeim, S.R., R. Freeman, B. Witt, and D.H. Barad. The Possible Attenuating Effects of Estrogen on Circadian Blood Pressure Variation Using 24 Hour Ambulatory Monitoring. Journal of the Society for Gynecologic Investigation, 1995. 2(2): p. 428.

27. Naz, R.K., A. Butler, B.R. Witt, D. Barad, and A.C. Menge. Levels of interferon-gamma and tumor necrosis factor-alpha in sera and cervical mucus of fertile and infertile women: implication in infertility. J Reprod Immunol, 1995. 29(2): p. 105-17.

28. Palan, P.R., B.L. Cohen, D.H. Barad, and S.L. Romney. Effects of smoking on the levels of antioxidant beta carotene, alpha tocopherol and retinol in human ovarian follicular fluid. Gynecol Obstet Invest, 1995. 39(1): p. 43-6.

29. Witt, B.R., D.H. Barad, P. Barg, B.L. Cohen, S.R. Lindheim, L. Testaiuti, and H.K. Amin. Basal serum follicle stimulating hormone (FSH) and estradiol levels as predictors of pregnancy in unstimulated donor insemination cycles. J Assist Reprod Genet, 1995. 12(3): p. 157-60.

30. Fisch, H., E.T. Goluboff, J.H. Olson, J. Feldshuh, S.J. Broder, and D.H. Barad. Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril, 1996. 65(5): p. 1009-14.

31. Kaali, S.G., D.H. Barad, and I.R. Merkatz. Avoiding trocar injuries--is there a fail-safe method?[comment]. Fertility & Sterility, 1996. 66(6): p. 1045-6.

32. Lindheim, S.R., D.H. Barad, B. Witt, E. Ditkoff, and M.V. Sauer. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet, 1996. 13(9): p. 745-7.

CV David Barad

33. Lindheim, S.R., D.H. Barad, M. Zinger, B. Witt, H. Amin, B. Cohen, H. Fisch, and P. Barg. Abnormal sperm morphology is highly predictive of pregnancy outcome during controlled ovarian hyperstimulation and intrauterine insemination. J Assist Reprod Genet, 1996. 13(7): p. 569-72.

34. Mukherjee, T., D. Barad, R. Turk, and R. Freeman. A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment. Am J Obstet Gynecol, 1996. 175(1): p. 105-9.

35. Borgatta, L., R.W. Jenny, L. Gruss, C. Ong, and D. Barad. Clinical significance of methohexital, meperidine, and diazepam in breast milk. J Clin Pharmacol, 1997. 37(3): p. 186-92.

36. Kaali, S.G., D.H. Barad, and I.R. Merkatz. Modified open laparoscopy through placement of an optical surgical obturator. Fertil Steril, 1997. 67(5): p. 969-71.

37. Kaali, S.G. and D.H. Barad. Direct laparoscopic entry using a sharp and dull trocar technique. Obstet Gynecol, 1997. 89(1): p. 156-7.

38. Johnson, S.R., G.L. Anderson, D. Barad, and M.L. Stefanick. The Women's Health Initiative: rationale, design and progress report. J Brit Menopause Soc, 1999. 5: p. 155-159.

39. Barad, D.H. and B.R. Witt. Multiple pregnancies and assisted reproductive technologies. J Womens Health Gend Based Med, 2000. 9(2): p. 101-7.

40. Bevilacqua, K., D. Barad, J. Youchah, and B. Witt. Is affect associated with infertility treatment outcome? Fertil Steril, 2000. 73(3): p. 648-9.

41. Anderson, G.L., H.L. Judd, A.M. Kaunitz, D.H. Barad, S.A. Beresford, M. Pettinger, J. Liu, S.G. McNeeley, and A.M. Lopez. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. Jama, 2003. 290(13): p. 1739-48.

42. Chen, Z., M.B. Pettinger, C. Ritenbaugh, A.Z. LaCroix, J. Robbins, B.J. Caan, D.H. Barad, and I.A. Hakim. Habitual tea consumption and risk of osteoporosis: a prospective study in the women's health initiative observational cohort. Am J Epidemiol, 2003. 158(8): p. 772-81.

43. Hsia, J., D. Barad, K. Margolis, R. Rodabough, P.G. McGovern, M.C. Limacher, A. Oberman, and S. Smoller. Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (The Women's Health Initiative). Am J Cardiol, 2003. 92(3): p. 264-9.

44. Santoro, N., B. Isaac, G. Neal-Perry, T. Adel, L. Weingart, A. Nussbaum, S. Thakur, H. Jinnai, N. Khosla, and D. Barad. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab, 2003. 88(11): p. 5502-9.

45. Stefanick, M.L., B.B. Cochrane, J. Hsia, D.H. Barad, J.H. Liu, and S.R. Johnson. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of

CV David Barad

participants. Ann Epidemiol, 2003. 13(9 Suppl): p. S78-86.

46. Lee, I., P.T. Finger, J.A. Grifo, A.R. Rausen, A. Rebarber, and D.H. Barad. Retinoblastoma in a child conceived by in vitro fertilisation. Br J Ophthalmol, 2004. 88(8): p. 1098-9.

47. Pal, L., P. Kovacs, B. Witt, S. Jindal, N. Santoro, and D. Barad. Postthaw blastomere survival is predictive of the success of frozen-thawed embryo transfer cycles. Fertil Steril, 2004. 82(4): p. 821-6.

49. Barad, D. and N. Gleicher. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril. 2005 Sep; 84(3):756.

50. Chen, Z., M. Maricic, T.L. Bassford, M. Pettinger, C. Ritenbaugh, A.M. Lopez, D.H. Barad, M. Gass, and M.S. Leboff. Fracture Risk Among Breast Cancer Survivors: Results From the Women's Health Initiative Observational Study. Arch Intern Med, 2005. 165(5): p. 552-8.

51. Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB. Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study. Fertil Steril 2005;84(2):374-83.

52. Chen, Z., M. Maricic, M. Pettinger, C. Ritenbaugh, A.M. Lopez, D.H. Barad, M. Gass, M.S. Leboff, and T.L. Bassford, Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer. Cancer, 2005.

53. Ockene, J.K., D.H. Barad, B.B. Cochrane, J.C. Larson, M. Gass, S. Wassertheil-Smoller, J.E. Manson, V.M. Barnabei, D.S. Lane, R.G. Brzyski, M.C. Rosal, J. Wylie-Rosett, and J. Hays, Symptom experience after discontinuing use of estrogen plus progestin. JAMA, 2005. 294(2): p. 183-93.

54. Prentice, R.L., R. Langer, M.L. Stefanick, B.V. Howard, M. Pettinger, G. Anderson, D. Barad, J.D. Curb, J. Kotchen, L. Kuller, M. Limacher, and J. Wactawski-Wende, Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the Discrepancy between Observational Studies and the Women's Health Initiative Clinical Trial. Am J Epidemiol, 2005. 162(5): p. 404-14.

55. Rebecca D. Jackson, M.D., Andrea Z. LaCroix, Ph.D., Margery Gass, M.D., Robert B. Wallace, M.D., John Robbins, M.D., Cora E. Lewis, M.D., Tamsen Bassford, M.D., Shirley A.A. Beresford, Ph.D., Henry R. Black, M.D., Patricia Blanchette, M.D., Denise E. Bonds, M.D., Robert L. Brunner, Ph.D., Robert G. Brzyski, M.D., Bette Caan, Dr.P.H., Jane A. Cauley, Dr.P.H., Rowan T. Chlebowski, M.D., Steven R. Cummings, M.D., Iris Granek, M.D., Jennifer Hays, Ph.D., Gerardo Heiss, M.D., Susan L. Hendrix, D.O., Barbara V. Howard, Ph.D., Judith Hsia, M.D., F. Allan Hubbell, M.D., Karen C. Johnson, M.D., Howard Judd, M.D., Jane Morley Kotchen, M.D., Lewis H. Kuller, M.D., Robert D. Langer, M.D., Norman L. Lasser, M.D., Marian C. Limacher, M.D., Shari Ludlam, M.P.H., JoAnn E. Manson, M.D., Karen L. Margolis, M.D., Joan McGowan, Ph.D., Judith K. Ockene, Ph.D., Mary Jo O'Sullivan, M.D., Lawrence Phillips, M.D., Ross L. Prentice, Ph.D., Gloria E. Sarto, M.D., Marcia L. Stefanick, Ph.D., Linda

CV David Barad

Van Horn, Ph.D., Jean Wactawski-Wende, Ph.D., Evelyn Whitlock, M.D., Garnet L. Anderson, Ph.D., Annlouise R. Assaf, Ph.D., David Barad, M.D., for the Women's Health Initiative Investigators. Calcium plus Vitamin D Supplementation and the Risk of Fractures. New England Journal of Medicine, 2006, Volume 354:669-683.

56. Gleicher, N.G. Barad, D. An evolutionary concept of polycystic ovarian disease: does evolution favour reproductive success over survival? RBMOnline, 2006. vol 12.

57. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 2007;24:629-34.

58. Barad DH, Weghofer A, Gleicher N. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007;109:1404-10.

59. Bredy TW, Wu H, Crego C, Zellhoefer J, Sun YE, Barad M. Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 2007;14:268-76.

60. Gleicher N, Barad D. DHEA and testosterone in the elderly. N Engl J Med 2007;356:636-7; author reply 7.

61. Gleicher N, Barad D, Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev 2007;7:42-5.

70. Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007;28:1-6.

62. Gleicher N, Barad DH. Mild versus standard in-vitro fertilisation techniques. Lancet 2007;369:1855; author reply -6.

63. Gleicher N, Barad DH. The choice of gender: is elective gender selection, indeed, sexist? Hum Reprod 2007.

64. Gleicher N, Weghofer A, Barad D. Update on the comparison of assisted reproduction outcomes between Europe and the USA: the 2002 data. Fertil Steril 2007;87:1301-5.

65. Gleicher N, Weghofer A, Barad D. Too old for IVF: are we discriminating against older women? J Assist Reprod Genet 2007;24:639-44.

66. Gleicher N, Weghofer A, Barad D. On the benefit of assisted reproduction techniques, a comparison of the USA and Europe. Hum Reprod 2007;22:624-6.

67. Gleicher N, Weghofer A, Li J, Barad D. Differences in ovarian function parameters between Chinese and Caucasian oocyte donors: do they offer an explanation for lower IVF pregnancy rates in Chinese women? Hum Reprod 2007;22:2879-82.

68. Pal L, Hailpern SM, Santoro NF, Freeman R, Barad D, Kipersztok S et al. Association of pelvic

CV David Barad

organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial. Menopause 2007;Publish Ahead of Print.

69. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Jama 2007;297:1465-77.

70. Weghofer A, Barad D, Li J, Gleicher N. Aneuploidy rates in embryos from women with prematurely declining ovarian function: a pilot study. Fertil Steril 2007;88:90-4.

71. Weghofer A, Munne S, Chen S, Barad D, Gleicher N. Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007.

72. Weghofer A, Schnepf S, Barad D, Gleicher N. The impact of luteinizing hormone in assisted reproduction: a review. Curr Opin Obstet Gynecol 2007;19:253-7.

73. Pal L, Hailpern SM, Santoro NF, Freeman R, Barad D, Kipersztok S et al. Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial. Menopause 2008;15:59-66.

74. Weghofer A, Munne S, Brannath W, Chen S, Tomkin G, Cekleniak N et al. The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. Hum Reprod 2008;23:499-503.

75. Gleicher N, Weghofer A, Oktay K, Barad D: Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging? Menopause. 2009;16(4):760-4.

76. Gleicher N, Weghofer A, Oktay K, Barad D: Can the FMR1 (fragile X) gene serve as predictor of response to ovarian stimulation? Reprod Sci. 2009;5: 462-7.

77. Gleicher N, Weghofer A and Barad D. Age-specific ovarian function. Expert Rev Obstet Gynecol. 2008;3(5): 595-600.

78. Gleicher N, Weghofer A, Oktay K, Barad D: Relevance of low triple CGG repeats on the FMR1 gene to ovarian reserve: Is there a normal range? RBMOnline. 2008;19(3):385-90.

79. Barad D, Weghofer A, Gleicher N: Comparing anti-Mullerian hormone (AMH) and follicle-stimulationg hormone (FSH) as predictors of ovarian function. Fertil Steril 2009;91(supl 4):1553-5.

80. Gleicher N, Weghofer A, Oktay K, Barad DH. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: A new infertility test? Acta Obstetrica et Gynecologica Scandinavica. 2009; 88(9):1024-30.

81. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. RBMOnline 2009:3:385-390.

CV David Barad

82. Gleicher N and Barad D.: Patients are entitled to maximal IVF pregnancy rates. Reprod Biomed Online 2009;18:599-602.

83. Gleicher N, Barad D et al..: Can the FMR1 (fragil X) gene serve as predictor of response to ovarian stimulation? Reprod Sci 2009;16:462-7.

84. Gleicher N, Weghofer A, Oktay K, Barad D.: Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)? Hum Reprod 2009;24:2395-400.

85. Gleicher N et al.: Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrionol 2009:7;108.

86. Weghofer A, Klein K, Stammler-Safar M, Worda C, Barad DH, Husslein P and Gleicher N: Can prematurity risk in twin pregnancies after in vitro fertilization be predicted? A retrospective study. Reprod Biol Endocrionol 2009;7:136.

87. Weghofer A, Klein K, Stammler-Safar M, Barad DH, Worda C, Husslein P and Gleicher N. Severity of prematurity risk in spontaneous and in vitro fertilization twins: does conception mode serve as a risk factor? Fertil Steril 2009:92(6):2116-2118.

88. Gleicher N, Barad D. “Patient-friendly” IVF. Expert Rev Obstet Gynecol 2010:5(1);1-4.

89. Gleicher N, Barad D. Can the FMR1 gene predict early ovarian aging? Women’s Health 2010:6(2);165-9.

90. Barad DH, Weghofer A, Goyal A, Gleicher N. Utility of age-specific anti-Mullerian hormone concentrations. RBMOnline 2011;22:284-91.

91. Gleicher N, Weghofer A, Barad DH: Anti-Mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril 2010, 94(7):2824-2827.

92. Gleicher N, Weghofer A, Barad DH. Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian aging. RBMOnline 2010;20(6):768-775.

93. Oktay K, Kim JY, Barad D, Babayev SN: Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol 2010, 28(2):240-244.

94. Weghofer A, Klein K, Stammler-Safar M, Worda C, Barad DH, Husslein P, Gleicher N. The impact of fetal gender on prematurity in dichorial twin gestations after in vitro fertilization. Reprod Bio Endocrin 2010,8:57.

95. Gleicher N, Barad DH. Further comments on the Suleman case. Expert Rev Obstet Gynecol 2010;5(5):501-2.

CV David Barad

96. Gleicher N, Barad DH. Misplaced obsession with prospectively randomized studies. RBMOnline 2010;21(4): 440-443.

97. Gleicher N, Weghofer A, Barad DH. Discordances between follicle stimulating hormone (FSH) and anti-Mullerian hormone (AMH) in female infertility. Reprod Biol Endocrionol 2010;8:64.

98. Gleicher N, Weghofer A, Barad DH. Can egg donor selection be improved? A pilot study. Reprod Biol Endocrinol 2010;8:76.

99. Gleicher N, Weghofer A, Barad DH. Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors. RBMOnline 2010;20:485-491.

100. Gleicher N, Weghofer A, Barad DH. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. RBMOnline 2010;21:360-365.

101. Espeland MA, Shumaker SA, Limacher M, Rapp SR, Bevers TB, Barad DH, Coker LH, Gaussoin SA, Stefanick ML, Lane DS et al: Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition. J Womens Health (Larchmt) 2010, 19(3):371-379

102. Gleicher N, Barad DH. The FMR1 gene as regulator of ovarian recruitment and ovarian reserve. Obstetrical and Gynecological Survey 2010. In Press.

103. Gleicher N, Weghofer A, Barad DH. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol 2010;8:140.

104. Gleicher N, Weghofer A, Lee IH, Barad DH. FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS One 2010 Dec 16;5(12):e15303.

105. Gleicher N, Weghofer A, Barad DH. Low-intensity IVF: real progress? Reprod Biomed Online;23:274-8, 2011.

106. Gleicher N, Weghofer A, Barad DH. Does chromosomally abnormal pregnancies really preclude autoimmune etiologies of spontaneous miscarriages? Autoimmunity Rev; 10:361-3, 2011.

107. Barad DH, Weghofer A, Gleicher N: Utility of age-specific serum anti-Mullerian hormone concentrations. Reprod Biomed Online 2011, 22(3):284-291.

108. Gleicher N, Weghofer A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril 2011, In pRess.

109. Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Repord Biol Endocrinol 2011 [Epub ahead of print].

110. Gleicher N, Weghofer A, Lee IH, Barad DH. Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/race. PLoS One 2011;6(4):e18781.

CV David Barad

111. Gleicher N, Barad DH. Gestational dermatosis shortly after implantation associated with parental class II HLA compatibility and maternal immune activation: preliminary report of a prospective case series. Dermatology 2011; DOI10.1159/000327377.

112. Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 2011;9:67.

113. Gleicher N, Weghofer A, Barad DH. Cutting edge assessment of the impact of autoimmunity on female reproductive success. J Autoimmunity 2011, In Press.

114. Weghofer A, Dietrich W, Ortner I, Bieglmayer C, Barad D, Gleicher N. Anti-Mullerian hormone levels decline under hormonal suppression: a prospective analysis in fertile women after delivery. Reprod Biol Endocrinol 2011;9(1):98.

115. Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 2011;9(1):116.

116. Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol;10:77, 2012.

117. Gleicher N, Kim A, Weghofer A, Barad DH. Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women. Reprod Biol Endocrinol;10:48, 2012.

118. Gleicher N, Kim A, Weghofer A, Barad DH. Towards a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo), hormone ratios per retrieved oocyte. J Clin Endocrinol Metab 97:995-1004, 2012.

119. Gleicher N, Weghofer A, Barad DH. A case-control pilot study of low intensity in vitro fertilization (LI-IVF) in good prognosis patients. Reprod Biomed Online 2011; In Press.

120. Gass ML et al. Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative. Menopause 2011;18(11):1160-71.

121. Weghofer A, Dietrich W, Barad DH, Gleicher N. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum Reprod2011;26:1905-9.

122. Gleicher N, Weghofer A, Kim A, Barad DH. The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve. PLoS ONE 2012;3(7):e33638.

123. Gleicher N, Weghofer A, Kim A, Barad DH. Comparison of ovarian FMR1 genotypes and sub-genotypes in oocyte donors and infertile women. J Assist Reprod Genet 2012; In Press.

124. Gleicher N and Barad DH. "Hype" or "hope": Ethical and practical considerations in association with clinical research in women with diminished ovarian reserve. Reprod Biomed Online; 25:98-102, 2012.

CV David Barad

125. Gleicher N, Barad DH. A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice. J Assist Reprod Genet;29:1159-66, 2012.

126. Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum Reprod;27:3287-93, 2012.

127. Weghofer A, Kim A, Barad DH, Gleicher N. Follicle stimulating hormone and anti-Mullerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort study. PLoS One;7:e34290, 2012.

128. Weghofer A, Tea MK, Barad DH, Kim A, Singer CF, Wagner K et al. BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"? PLoS One;7:e44753, 2012.

129. Gleicher N, Kushnir VA, Barad DH. What ‘misguided campaign’ against single embryo transfer? Human Reproduction 2013; Epub ahead of print.

130. Barad DH, Kim A, Kubba H, Weghofer A, Gleicher N. Do hormonal contraceptions prior to in vitro fertilization (IVF) negatively affect oocyte yields? A pilot study. Reprod Biol Endocrinol 2013;11:28.

131. Gleicher N, Kim A, Kushnir V, Weghofer A, Shohat-Tal A, Lazzaroni E et al. Clinical Relevance of Combined FSH and AMH Observations in Infertile Women. J Clin Endocrinol Metab;98:2136-45, 2013.

132. Gleicher N, Kim A, Michaeli T, Lee HJ, Shohat-Tal A, Lazzaroni E et al. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod;28:172-7, 2013.

133. Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E et al. Hypoandrogenism in association with diminished functional ovarian reserve. Hum Reprod;28:1084-91, 2013.

134. Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ et al. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet;30:49-62, 2013.

135. Kushnir VA, Kim A, Gleicher N, Barad DH. A pilot trial of large versus small diameter needles for oocyte retrieval. Reprod Biol Endocrinol 2013; 11:22.

136. Kushnir VA, Barad DH, Gleicher N. Defining assisted reproductive technology success. Fertil Steril;100:e30, 2013.

137. Gleicher N, Kim A, Barad DH, Shohat-Tal A, Lazzaroni E, Michaeli T, Lee HJ, Kushnir VA,

CV David Barad

Weghofer A. FMR1-dependent variability of ovarian aging patterns is already apparent in young oocyte donors. Reprod Biol Endocrinol 2013;11(1):80.

138. Kushnir VA, Barad DH, Gleicher N. Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts. Obstet Gynecol;121:1361, 2013.

139. Weghofer A, Kim A, Barad DH, Gleicher N. Age at menarche: a predictor of diminished ovarian function? Fertil Steril;100:1039-43, 2013.

140. Gleicher N, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH. Is androgen production in association with immune system activation potential evidence for existence of a functional adrenal/ovarian autoimmune system in women? Reprod Biol Endocrinol 2013;11:58.

141. Sen A, Kushnir VA, Barad DH, Gleicher N. Endocrine autoimmune diseases and female infertility. Nat Rev Endocrinol; 10:37-50, 2014.

142. Gleicher N, Kushnir VA, Barad DH. Therapeutic interventions into early stages of follicle maturation: a new treatment paradigm after over 50 years of modern infertility therapy. Endocrinology;154(10):3498-501, 2013.

143. Gleicher N, Weghofer A, Barad DH. Do BRCA1/2 mutations and low FMR1 alleles interact or not? Eur J Hum Genet; 22:155-6, 2014.

144. Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening is alive and very well: Really? Fertil Steril;100(5):e36, 2013.

145. Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Gleicher N. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates. Fertil Steril;100(3):710-715, 2014.

146. Kushnir VA, Vidali A, Barad DH, Gleicher N. The status of public reporting of clinical outcomes in assisted reproductive technology. Fertil Steril;100:736-41, 2013.

147. Gleicher N, Kushnir VA, Barad DH. The danger of ignoring pregnancy and delivery rates in ART. Hum Reprod 2013, Epub ahead of print.

148. Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review. Reprod Biol Endocrinol 2014; 12:22.

149. Kushnir VA, Yu Y, Barad DH, Weghofer A, Himaya E, Lee H-J, Wu Y-G, Shohat-Tal A, Lazzaroni-Tealdi E, Gleicher N. Utilizing FMR1 gene mutations as predictors of treatment success in human in vitro fertilization. PLoS ONE 2014, in press.

150. Gleicher N, McAlpine JN, Gilks CB, Kushnir VA< Lee H-J, Wu Y-G, Lazzaroni-Tealdi E, Barad DH. Absence of BRCA/FMR1 correlations in women with ovarian cancers. PLoS ONE 2014, in

CV David Barad

press.

151. Kushnir VA, Barad DH, Gleicher N. Ovarian reserve screening prior to contraception? Reprod Biomed Online 2014; in press.

152. Gleicher N, Kushnir VA, Weghofer A, Barad DH. The “graying” of infertility services: an impending revolution nobody is ready for. Reprod Biol Endocrinol 2014; In press.

153. Gleicher N, Kushnir VA, Weghofer A, Barad DH. How the FMR1 gene became relevant to female fertility and reproductive medicine. Frontiers Genet 2014; In press.

154. Barad DH, Kushnir VA, Lee H-J, Lazzaroni-Tealdi E, Gleicher N. Effects of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study. Reprod Biol Endocrinol 2014; In press.

155. Kushnir VA, Barad DH, Gleicher N, Ovarian reserve screening before contraception? Reproductive Biomedicine Online 2014. Epub ahead of print.

156. Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee HJ, Barad D, Gleicher N, Hammes SR. Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3008-13. doi: 10.1073/pnas.1318978111.

157. Kushnir VA, Khanna P, Barad DH, Gleicher N. Establishment of comparative performance criteria for IVF centers: correlation of live birth rates in autologous and donor oocyte IVF cycles. Reprod Biol Endocrinol. 2014 Dec 4;12:122. doi: 10.1186/1477-7827-12-122.

158. Gleicher N, Kushnir VA, Barad DH. Is it time for a paradigm shift in understanding embryo selection? Reprod Biol Endocrinol. 2015 Jan 11;13:3. doi: 10.1186/1477-7827-13-3.

159. Weghofer A, Himaya E, Kushnir VA, Barad DH, Lazzaroni-Tealdi E, Yu Y, Wu YG, Gleicher N. Some aspects of interactivity between endocrine and immune systems required for successful reproduction. Reprod Biol Endocrinol. 2015 Apr 11;13:29. doi: 10.1186/s12958-015-0020-5.

160. Gleicher N, Kushnir VA, Barad DH. Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm. Reprod Biol Endocrinol. 2015 Apr 18;13:34. doi: 10.1186/s12958-015-0026-z.

161. Shohat-Tal A, Sen A, Barad DH, Kushnir V, Gleicher N. Genetics of androgen metabolism in women with infertility and hypoandrogenism. Nat Rev Endocrinol. 2015 Jul;11(7):429-441. doi: 10.1038/nrendo.2015.64. Epub 2015 May 5.

162. Gleicher N, McCulloh DH, Kushnir VA, Ganguly N, Barad DH, Goldman KN, Kushnir MM, Albertini DF, Grifo JA. Is there an androgen level threshold for aneuploidy risk in infertile women? Reprod Biol Endocrinol. 2015 May 6;13:38. doi: 10.1186/s12958-015-0034-z.

163. Weghofer A, Himaya E, Kushnir VA, Barad DH, Gleicher N. The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: a case-control study. Reprod Biol Endocrinol. 2015 May 15;13:43. doi: 10.1186/s12958-015-0041-0.

164. Barad DH, Kushnir VA, Albertini D, Gleicher N. CDC analysis of ICSI/autism: association is not

causation. Hum Reprod. 2015 Jul;30(7):1745-6. doi: 10.1093/humrep/dev104. Epub 2015 May

CV David Barad

13. 165. Gleicher N, Kushnir VA, Barad DH. Why prospectively randomized clinical trials have been rare in

reproductive medicine and will remain so? Reprod Sci 2015; Epub ahead of print.

166. Wu YG, Barad DH, Kushnir VA, Lazzaroni E, Wang Q, Albertini DF, Gleicher N. Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J Endocrinol 2015;226(3)):167-80.

167. Kushnir VA, Barad DH, Albertini DF, Sarmon SK, Gleicher N. Outcomes of fresh and

cryopreserved oocyte donation. JAMA 2015;314(6)623-4.

168. Gleicher N, Yu Y, Himaya E, Barad DH, Weghofer A, Wu YG, Albertini DF, Want VQ, Kushnir VA. Early decline in functional ovarian reserve in young women with low (CGGn<26) FMR1 gene alleles. Trans Res 2015;epub ahead of print.

169. Shohat-Tal A, Sen A, Barad DH, Kushnir VA, Gleicher N. More on the conversion of DHEA to

testosterone. Nat Rev Endocrinol 2015;11(9):521.

170. Kushnir VA, Halevy N, Barad DH, Albertini DF, Gleicher N. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome. J Ovarian Res 2015;8(1):45.

171. Lee HJ, Barad DH, Kushnir VA, Shohat-Tal A, Lazzaroni-Tealdi E, Wu YG, Gleicher N. Rescue

in vitro maturation (IVM) of immature oocytes in stimulated cycles in women with low functional ovarian reserve (LFOR). Endocrine 2015;9 (1-7).

172. Gleicher N, Vega, Darmon SK, Weghofer A, Barad DH, Wu YG, Wang Q, Zhang L, Albertini D,

Kushnir VA. Live-birth rates in very poor prognosis patients who are defined as poor responders under the Bologna criteria with nonelective single embryo, two-embryo, and three or more embryos transferred. Fertility & Sterility 2015;epub ahead of print

173. Lazzaroni-Tealdi E, Barad DH, Albertini DF, Yu Y, Kushnir VA, Russell H, Wu YG, Gleicher N. Oocyte scoring enhances embryo-scoring in predicting pregnancy chances with IVF where it counts most. PLoS ONE 2015;10(12:e014362.

174. Weghofer A, Barad DH, Darmon S, Kushnir VA, Gleicher N. What affects functional ovarian reserve, thyroid function or thyroid autoimmunity? Reprod Biol Endocrinol 2016;14(1):26.

175. Kushnir VA, Barad DH, Albertini DF, Darmon SK, Gleicher N. Effect of Embryo Banking on U.S. National Assisted Reproductive Technology Live Birth Rates. PLoS One 2016;11(5):e0154620.

176. Gleicher N, Kushnir V, Albertini D, Barad DH. Improvements in IVF in women of advanced age. J Endocrinol 2016;pii: JOE-16-0105. [Epub ahead of print]

177. Gleicher N, Kushnir VA, Barad DH. Risks of spontaneously and IVF-conceived singleton and twin pregnancies differ, requiring reassessment of statistical premises favoring elective single embryo transfer (eSET). Reprod Biol Endocrinol 2016;14(1):25.

CV David Barad

178. Gleicher N, Kushnir VA, Weghofer A, Barad DH. The importance of adrenal hypoandrogenism in infertile women with low functional ovarian reserve: a case study of associated adrenal insufficiency. Reprod Biol Endocrinol 2016;0.599305555555556

179. Kushnir VA, Darmon SK, Albertini DF, Barad DH, Gleicher N. Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011-2012. Fertil Steril 2016;pii: S0015-0282(16)00140-0. doi: 10.1016/j.fertnstert.2016.02.026. [Epub ahead of print]

180. Kushnir VA, Solouki S, Sarig-Meth T, Vega MG, Albertini DF, Darmon SK, Deligdisch L, Barad DH, Gleicher N. Systemic Inflammation and Autoimmunity in Women with Chronic Endometritis. Am J Reprod Immunol 2016;doi: 10.1111/aji.12508. [Epub ahead of print]

181. Gleicher N, Kushnir VA, Barad DH. The impact of patient preselection on reported IVF outcomes. J Assist Reprod Genet 2016;33(4):455-9.

182. Gleicher N, Seier K, Kushnir VA, Weghofer A, Wu YG, Wang Q, Albertini DF, Barad DH. Associations between peripheral androgens and cortisol in infertile women. J Steroid Biochem Mol Biol 2016;158:82-9.

183. Gleicher N, Kushnir VA, Barad DH. Randomized controlled trial of minimal stimulation versus conventional in vitro fertilization. Am J Obstet Gynecol 2016;214(3):412-3.

184. Gleicher et al. How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields. Endocrine 2016;54(2):476-483.

185. Gleicher N et al. Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos. Reprod Biol Endocrinol 2016;14(1):514.

186. Gleicher N et al. In reference to 'Strategies to manage refractory endometrium: state of the art 2016'. Reprod Biomed Online 2016;33(5):604.

187. Wu YG et al. Different effectiveness of closed embryo culture system with time-lapse imaging (EmbryoScope(TM)) in comparison to standard manual embryology in good and poor prognosis patients: a prospectively randomized pilot study. Reprod Biol Endocrinol 2016;14(1):49.

188. Vega M et al. Anti-mullerian hormone levels decline with the presence of antiphospholipid antibodies. Am J Reprod Immunol 2016;76(4):333-337.

189. Barad DH et al. The importance of redundancy of functional ovarian reserve when investigating potential genetic effects on ovarian function. J Assist Reprod Genet 2016;33(9):1157-1160.

190. Vega MG et al. IVF outcomes in average- and poor-prognosis infertile women according to the number of embryos transferred. Reprod Biomed Online 2016;33(3):370-375.

191. Gleicher N et al. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH. J Transl Med 2016;14(1):172.

192. Sermon K et al. The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Mol Hum Reprod 2016;22(8):845-857.

193. Gleicher N et al. Response to comment on: Gleicher N et al., 2016. Reprod biol endocrinol Sep 5;14(1):54. Reprod Biol Endocrinol 2017;15(1):23.

194. Gleicher N et al. Elective single-embryo transfer (eSET) reduces pregnancy rates and should only be used in exceptional circumstances: FOR: The statistically flawed model of eSET. BJOG 2017;124(5):755.

195. Kushnir VA et al. Age-Specific IVF Outcomes in Infertile Women With Baseline FSH Levels ≥20 mIU/mL. Reprod Sci 2017; epub ahead of print.

CV David Barad

196. Kushnir VA et al. Systematic review of worldwide trends in assisted reproductive technology 2004-2013. Reprod Biol Endocrinol 2017;15(1):6.

197. Gleicher N et al. New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens. J Steroid Biochem Mol Biol 2017;167:144-152.

198. Barad DH et al. Focus on recurrent miscarriage phenotypes. Fertil Steril 2017;107(1):64-65. 199. Kushnir VA et al. Utilization of third-party in vitro fertilization in the United States. Am J Obstet

Gynecol 2017;216(3):266.e1-266.e10. 200. Kushnir VA et al. CDC-reported assisted reproductive technology live-birth rates may mislead

the public. Reprod Biomed Online 2017;35(2):161-164. 201. Barad DH et al. Association of skewed X-chromosome inactivation with FMR1 CGG repeat

length and anti-Mullerian hormone levels: a cohort study. Reprod Biol Endocrinol 2017;15(1):34. 202. Gleicher N et al. A single trophectoderm biopsy at blastocyst stage is mathematically unable to

determine embryo ploidy accurately enough for clinical use. Reprod Biol Endocrinol 2017;15(1):33.

203. Barad DH, Darmon SK, Kushnir VA, Albertini DF, Gleicher N. Impact of preimplantation genetic screening on donor oocyte-recipient cycles in the United States. Am J Obstet Gynecol 2017; 217(5):576.

204. Kushnir VA, Seifer DB, Barad DH, Sen A, Gleicher N. Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine. J Assist Reprod Genet 2017; 34(9):1105-1113.

205. Shapiro AJ, Darmon SK, Barad DH, Albertini DF, Gleicher N, Kushnir VA. Effect of race and ethnicity on utilization and outcomes of assisted reproductive technology in the USA. Reprod Biol Endocrinol 2017;15(1):44.

206. Gleicher N, Kushnir VA, Barad DH. How PGS/PGT-A laboratories succeeded in losing all credibility. Reprod Biomed Online 2018;37(2):242-245.

207. Gleicher N, Kushnir VA, Darmon SK, Albertini DF, Barad DH. Older women using their own eggs? Issue framed with two oldest reported IVF pregnancies and a live birth. Reprod Biomed Online 2018;37(2):172-177.

208. Gleicher N, Kushnir VA, Barad DH. Impact of androgen supplementation on the follicular endocrine milieu in women with hypoandrogenism. Reprod Biomed Online 2018;36(6):719-720.

209. Wang Q, Barad DH, Darmon SK, Kushnir VA, Wu YG, Lazzaroni-Tealdi E, Zhang L, Albertini DF, Gleicher N. Reduced RNA expression of the FMR1 gene in women with low (CGGn<26) repeats. PLoS ONE 2018;13(12): e0209309.

210. Wu YG, Barad DH, Kushnir VA, Wang Q, Zhang L, Darmon SK, Albertini DF, Gleicher N. With low ovarian reserve, Highly Individualized Egg Retrieval (HIER) improves IVF results by avoiding premature luteinization. J Ovarian Res 2018;11(1):23.

211. Kushnir VA, Darmon SK, Barad DH, Gleicher N. Degree of mosaicism in trophectoderm does not predict pregnancy potential: a corrected analysis of pregnancy outcomes following transfer of mosaic embryos. Reprod Biol Endocrinol 2018;16(1):6.

212. Gleicher N, Kushnir VA, Darmon SK, Wang Q, Zhang L, Albertini DF, Barad DH. Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with advancing age. Endocrine 2018;59(3):661-676.

213. Kushnir VA, Darmon SK, Barad DH, Gleicher N. New national outcome data on fresh versus cryopreserved donor oocytes. J Ovarian Res 2018;11(1):2.-p

CV David Barad

214. Kushnir VA, Darmon SK, Barad DH, Gleicher N. Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation. BMJ Open 2018;8(11):e023124.

215. Kushnir VA, Darmon SK, Barad DH, Weghofer A, Gleicher N. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women. Endocrine 2018; Epub ahead of print.

216. AJ, Darmon SK, Barad DH, Gleicher N, Kushnir VA. Vitamin D levels are not associated with ovarian reserve in a group of infertile women with a high prevalance of diminished ovarian reserve. Fertil Steril 2018;110(4):761-766.e1.

217. Gleicher N, Kushnir VA, Barad DH. Unexplained infertility. Lancet 2018; 392(10157):1516-1517.

218. Patrizio P, Shoham G, Shoham Z, Leong M, Barad DH, Gleicher N. Worldwide live births following the transfer of chromosomally "Abnormal" embryos after PGT/A: results of a worldwide web-based survey. J Assist Reprod Genet 2019; epub ahead of print.

219. Gleicher N, Barad DH. Assessing in-vitro fertilization at age 40 years. Lancet 2019;393(10177):1181-3.

220. Gleicher N, Barad DH. Not even noninvasive cell-free DNA can rescue preimplantation genetic testing. Proc Natl Acad Sci USA 2019; Epub ahead of print.

221. Gleicher N, Kushnir VA, Barad DH. Worldwide decline of IVF birth rates and its probable causes. Hum Reprod Open 2019; 2019(3):hoz017.

B. Books, Chapters in Books, and Review Articles

Books:(1-14)

1. Barad D. In Vitro Fertilization. In: Martini L, ed. Encyclopedia of Endocrine Diseases. Amsterdam Boston; 2004:Elsevier Academic Press.

2. Barad D, Schiff I. Hirsutism and Virilism. In: Hare JW, ed. Signs and Symptoms of Endocrine and Metabolic Disorder. London Mexico New York: J.B. Lippincott Co; 1986:68.

3. Schneider E, Fox H, Barad D, Farber R. Fluorescence polarization values of amniotic fluid collected from the vagina after rupture of membranes. In: Yearbook of Pathology and Clinical Pathology; 1987.

4. Barad D. Work-up of the Infertile Couple. In: Barad D, ed. Infertility and Reproductive Medicine Clinics of North America. Philadelphia London Toronto Montreal Tokoyo: WB Saunders Company; 1991:WB Saunders Company.

5. Barad D. Epidemiology of Infertility. In: Barad D, ed. Workup of the Infertile Woman. Philadelphia London Toronto Montreal Tokoyo: WB Saunders Company; 1991:255.

CV David Barad

6. Kaali S, Bartfai G, Feinman M, Barad D. Battery-operated birth control devices based on the effect of low electrical current on sperm motility. In: Female contraception and male fertility regulation. Carnforth, Lancs, UK ; Park Ridge, N.J., USA: Parthenon Publishing Group; 1991:165.

7. Mednick R, Mednick E, Ratz O, Barad D. Adoption: To have a family, not just a pregnancy. In: Barad D, ed. Workup of the Infertile Woman. Philadelphia London Toronto Montreal Tokoyo: WB Saunders Company; 1991.

8. Testaiuti L, Barad D. Office Management of Couples with Impaired Fertility. In: Barad D, ed. Workup of the Infertile Woman. Philadelphia London Toronto Montreal Tokoyo: WB Saunders Company; 1991.

9. Pollard J, Pampfer S, Daiter E, Barad D, Areci R. Colony-stimulating factor I in the mouse and human uteroplacental unit. In: Schomberg D, ed. Growth factors in reproduction. New York: Springer-Verlag; 1991.

10. Barad D, ed. Perimenopausal Health Care. Philadelphia: WB Saunders Company; 1993.

11. Witt B, Barad D. Management of endometriosis in women over forty years of age. In: Barad D, ed. Perimenopausal Health Care. Philadelphia London Toronto Montreal Tokoyo: WB Saunders Company; 1993:349.

12. Barad D, Cohen B. Oocyte Donation Program at Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York. In: Cohen CB, ed. New ways of Making Babies: the case of egg donation. Bloomington, Ind: Indiana University Press; 1996:15.

13. Barad D. Turners Syndrome. In: Knobil E, Neill J, eds. Encyclopedia of Reproduction. Burlington London San Diego: Academic Press; 1999.

14. Charney P, Boynton U, Barad D, Polansky M. The Pelvic Examination. In: Ryden J, Blumenthal P, eds. Practical Gynecology - A Guide for the Primary Care Physician. Philadelphia; 2002:American College of Physicians.

15. Barad, DH. Approach to the Gynecological Patient. In: The Merck Manual. 18th Edition. Merck Research Lboratories, Whithouse Station. NJ. 2006.

16. Gleicher N, Barad DH. Dehydroepiandrosterone. In: Kovacs G ed. How to improve your ART success rates: An evidence-based review of adjuncts to IVF. Cambridge University Press, London, UK. 2011.

CV David Barad

C. Abstracts: (1-73)

1. Baxi L, Reece E, Barad D, Farber R, Williams A. Glycosylated hemoglobin and hemoglobinopathies in pregnancy In: 29th Annual Meeting of the Society for Gynecologic Investigion 1982 March 24-27, 1982; Dallas, Tx; 1982.

2. Baxi L, Barad D, Reece E, Farber R. Significance of glycosylated hemoglobin in class A diabetes in pregnancy In: 29th Annual Meeting of the Society for Gynecologic Investigion 1982 March 24-27, 1982; Dallas, Tx; 1982.

3. Barad D, Kaali S, Bartfai G, Feinman M. Hysteroscopic location of "lost IUD" during first-trimester pregnancy In: AAGL 16th Annual Meeting 1987 Nov 10-15, 1987; San Francisco, CA 1987.

4. Bartfai G, Feinman M, Barad D, Kaali S. Long-Term Follow-up of Laparoscopic Female Sterilization In: AAGL 16th Annual Meeting 1987 Nov 10 -15, 1987 San Francisco, CA 1987.

5. Feinman M, Barad D, Bartfai G, Kaali S, Merkatz I. The true incidence of uterine perforation during laparoscopic sterilization In: Second World Congress of Endoscopic Female Sterilization 1987 July 9-12, 1987; Colonial Williamsburg, VA 1987.

6. Feinman M, Bartfai G, Kaali S, Barad D, Merkatz I. Treatment Independent Pregnancies After In Vitro Fertilization and Embryo Transfer In: Vth World Congress IVF-ET; 1987 April 27-30 (AP-663) Norfolk, VA 1987.

7. Kaali S, Bartfai G, Barad D, Feinman M, Merkatz I. Direct Insertion of the Laparoscopic Trocar in Patients with Previous Abdominal Surgery In: ACOG 35th Meeting 1987 April 27-30, 1987 Las Vegas, NV 1987.

8. Kaali S, Barad D, Bartfai G, Feinman M, Merkatz I. Safely Conducted Laparoscopic Sterilization in Women with Previous Umbilical Hernia Repairs In: Second World Congress of Endoscopic Female Sterilization 1987 July 9-12, 1987 Colonial Williamsburg, VA 1987.

9. Kaali S, Bartfai G, Feinman M, Barad D. Outpatient Laparoscopy for Obese Women with Previous Abdominal Surgery In: AAGL Annual Meeting 1987 Nov 10 -15, 1987 San Francisco, CA 1987.

10. Palan P, Cohen B, Feinman M, Barad D, Mikhail M, Basu J, Romney S. B-Carotene and Vitamin A in Human Ovarian Follicular Fluid In: Presented at Society for Gynecologic Investigation; 1987 March 15-19, 1989; San Diego, CA; 1987.

11. Barad D. Availability of Oocytes for Donation from an Ambulatory Sterilization Program In: AAGL 17th Annual Meeting 1988 November 9-13 1988 Dallas, TX 1988.

12. Feinman M, Barad D, Barg P, Cohen B. The effect of tubal pathology on pregnancy rates following gamete intrafallopian tube transfer In: Society for Gynecologic Investigion 1988 Oct 3-

CV David Barad

8, 1988 Atlanta, Georgia 1988.

13. Barad D, Freeman R, Speranza M, Damiano A, Feinman M. Effect pf dietary fat on absorption of micronized estradiol In: Endocrine Society 71st Annual Meeting 1989 June 1989 Seattle, WA 1989.

14. Barad D, Feinman M, Gruss L, Borgatta L, Kaali S. Outpatient management of ectopic pregnancy In: 18th Annual World Congress of Gynecological Endoscopy AAGL 1989 Sept. 20-24, 1989; Washington D.C. ; 1989.

15. Barg P, Feinman M, Barad D, Feichtinger W. Ultra-Rapid Freezing of Mouse Embryos In: Presented at the VI World Congress In Vitro Fertilization and Alternate Assisted Reproduction; 1989 April 2-7, 1989; Jerusalem, Israel; 1989.

16. Borgatta L, Gruss L, Barad D, Kaali S. Direct trocar insertion versus Verres needle use for laparoscopic tubal sterilization In: ACOG 37 Meeting 1989 1989 Atlanta 1989 1989.

17. DH B, W F. Ovarian and uterine blood flow by transvaginal Doppler ultrasound suring ovulation induction. In: Syllabus Endovaginal Sonography; 1989; 1989.

18. Feinman M, Barad D, Hailparn T, Cohen B, Barg P, Freeman R. The Use of Parenteral Estradiol Valerate in a Donor Oocyte Program In: VI World Congress In Vitro Fertilizion and Alterne Assisted Reproduction 1989 April 2-7, 1989; Jerusalem, Israel, ; 1989.

19. Feinman M, Barad D, Cohen B, Barg P, Ratz O. The value of (Gamete intrafallopian tube transfer) GIFT for women over forty In: 18th Annual World Congress of Gynecological Endoscopy AAGL 1989 Sept. 20-24, 1989; Washington D.C. ; 1989.

20. Freeman R, Duvivier R, Barad D, Weller R. The effect of depot medroxyprogesterone acetate on cholesterol,lipoprotein cholesterol and triglicerides in postmenopausal women In: New York Academy of Sciences - North american Menopause Society 1989 Sept 21 - 23, 1989; New York, NY; 1989.

21. Gruss L, Barad D, Borgatta L, Kaali S. Management of unsuspected ectopic pregnancy at the time of sterilization in an ambulatory surgery center In: 18th Annual World Congress of Gynecological Endoscopy AAGL 1989 Sept. 20-24, 1989; Washington D.C. ; 1989.

22. Kaali S, Barad, DH, Bartfai, G Laparoscopic recovery of fetal calvarium at midtrimester abortion In: 2nd World Congress of Gynecologic Endoscopy Clermont-Ferrand 1989 June 5-7, 1989 Paris, France 1989.

23. Szigetvari I, Feinman M, Barad D, Bartfai G, Kaali S. The Association of previous abdominal surgery and adhesions in laparoscopic sterilization patients In: 17th Annual Meeting First North American/South American Congress of Gynecologie Endoscopy 1989 November 9-13 1989 Dallas, TX 1989.

24. Barad D, Feinman M, Cohen B, Unfried E, Feichtinger W. Radioactive cesium in follicular fluid

CV David Barad

and reproductive performance In: Society for Gynecological Investigion 1990 March 21-24, 1990 St Louis, Mo 1990.

25. Barad D, Feinman M, Kaali S. Outpatient management of ectopic pregnancy In: VII World Congress on Human Reproduction 1990 June 1990 Helsinki - Finland 1990.

26. Barad D, Jaffe S, Kalli S, Merkatz I. Predictive vale of reproductive factors for pelvic/abdominal adhesions In: VII World Congress on Human Reproduction 1990 June 1990 Helsinki - Finland 1990.

27. Barad D, Barg P, Feinman M, Feichtinger W. The effect of a two component fibrin sealant on mouse embryo culture In: VII World Congress on Human Reproduction 1990 June 1990 Helsinki - Finland 1990.

28. Barad D, Feinman M. A comparison of treatment with danazol, GnRH agonist, or no treatment prior to laparoscopic treatment of endometriomas In: AAGL 19th Annual Meeting 1990 Nov 14-18,1990 Orlando, Florida 1990.

29. Borgatta L, Gruss L, Barad D. Effect of local application of bupivicaine on discomfort after tubal sterilization with falope rings In: Associion of Reproductive Health Professionals 1990 1990; 1990.

30. Borgatta L, Barad D. Prolonged retention of laminaria fragments In: Associion of Reproductive Health Professionals 1990 1990; 1990.

31. Cohen B, Feinman M, Barad D. Ovulation induction for in vitro fertilization using a programmed stimulation protocol. In: American Fertility Society 46th Annual Meeting; 1990 October 15-18; Washington, D.C.; 1990.

32. Daiter E, Pampfer S, Barad D, Pollard J. Temporal expression and location of colony stimulating factor-1 (CSF-1) in the human female reproductive tract. In: American Fertility Society 46th Annual Meeting; 1990 October 15-18; Washington, D.C.; 1990.

33. Feichtinger W, Kemeter P, Herczag K, Barad D. Ovarian and uterine blood flow by transvaginal Doppler ultrasound during ovulation induction In: European Society of Reproductive Endocrinology 1990 July 1990; 1990.

34. Feinman M, Pesce R, Olah J, Barad D. A simplified approach to monitoring early pregnancies In: AAGL 19th Annual Meeting 1990 Nov 14 - 18 , 1990 Orlando, Florida 1990.

35. Freeman R, Small M, Thornhill B, Barad D. The effect of smoking on bone density in women with premature ovarian failure vs normal women. In: American Fertility Society 46th Annual Meeting; 1990 October 15-18; Washington, D.C.; 1990.

36. Kaali S, Bartfai G, Feinman M, Barad D. Utilizing the effect of low electrical current to improve the efficacy of existing barrier birth control devices In: VII World Congress on Human Reproduction 1990 June 1990 Helsinki - Finland 1990.

CV David Barad

37. Kaali S, Csakany G, Szigetvari I, Feinman M, Barad D. A two visit protocol for screening ectopic pregnancies in low risk populations In: VII World Congress on Human Reproduction 1990 June 1990 Helsinki - Finland 1990.

38. Kaali S, Bartfai G, Szigetari I, Csankany G, Olah J, Barad D, Feinman M. Fifteen year experience with outpatient laparoscopic sterilization in a free standing facility In: AAGL 19th Annual Meeting 1990 Nov 14 - 18 , 1990; Florida 1990.

39. Klugman S, Barad D. Continuation of intrauterine pregnancy after laparoscopic treatment of a heterotopic ectopic pregnancy under local anesthesia In: AAGL 19th Annual Meeting 1990 Nov 14 - 18 , 1990 Orlando, Florida 1990.

40. Bar-Chama N, Fisch H, Barg P, Cohen B, Barad D. The use of flow cytometry for the characterization and quantitation of seminal leukocytes In: American Fertility Society 1991 October 1991 1991.

41. Barad D, Barg P, Pesce R, Cohen B, Cohen E, Witt B. Retrieval and in vitro maturation of germinal vesicle bearing oocytes from women undergoing tubal ligation. In: 7th World Congress on In Vitro Fertilizion; 1991 June 30 - July 3; Paris, France; 1991.

42. Barg P, Novogrodsky R, Barad D, Fisch H. Sperm penetration assay (SPA) results in patients with abnormal sperm morphology In: American Fertility Society 1992 November 1992; 1992.

43. Barg P, Spitzer C, Barad D. High frequency of morphology abnormalities in frozen donor sperm In: American Fertility Society 1992 November 1992; 1992.

44. Cohen B, Palan P, Barad D, Witt B, Zaratzian A, Romney S. Ovarian follicular fluid Beta-carotene levels in IVF cycles In: American Fertility Society 1992 November 1992; 1992.

45. Freeman R, Benedict A, Barad D. The effect of swimming on bone density of women aged 60-85 In: North American Menopause Society 1992 September 1992 1992.

46. Freeman R, Thornhill B, Haberman S, Barad D. Vertebral bone density is reduced by smoking but not by hypeprolactinenia In: American Fertility Society 1992 November 1992 1992.

47. Freeman R, Mukherjee T, Turk R, Barad D. Comparison of Dexa bone density in women with endometriosis or leiomyomata In: Society for Gynecological Investigion 1992 March 1992 1992.

48. Freeman R, Barad D. Smoking decreases bone density in premenopausal women but not in postmenopausal women In: 49th American Fertility Society 1993 October 1993; Montreal, Canada 1993.

49. Witt B, Barad D, Cohen B, Pollard J. Colony stimulating factor-1 in human follicular fluid In: 4oth Annual meeting of the Society for Gynecological Investigion 1993 April 1993; Toronto, Canada 1993.

50. Amin H, Witt B, Testaiuti L, Cohen B, Lindheim S, Barg P, Barad D. Donor insemination: Cycle

CV David Barad

day 3 serum follicle stimulating hormone (FSH) and estradiol as predictors of pregnancy. In: Presented at the 50th American Fertility Society; 1994 November 5-10, 1994; San Antonio, Texas; 1994.

51. Freeman R, Schwalb T, Barad D. Ambulatory blood pressure before and after estrogen replacement therapy with pemarin or estraderm patches In: 50th American Fertility Society 1994 November 5-10, 1994 San Antonio 1994.

52. Lindheim S, Barg P, Testauiti L, Cohen B, Witt B, Amin H, Barad D. A comparison of treatment regimens in the poor responder in an In Vitro Fertilization (IVF) program In: 50th American Fertility Society 1994 November 5-10, 1994 San Antonio, TX 1994.

53. Barad D, Lindheim S, Zinger M, Witt B, Cohen B, Amin H, Fisch H, Barg P. Sperm morphology predicts pregnancy more accurately after intrauterine insemination than after in vitro fertilization In: American Society for Reproductive Medicine 51rst Annual Meeting 1995 Oct 7-12, 1995 1995.

54. Barg P, Lindheim, SR, Zinger M, Spitzer C, Amin H, Cohen B, Witt B, Fisch H, Barad D. Predictive Value of Single Versus Multiple Morphological Assessment of Spermatozoa after in Vitro Fertilization In: American Society for Reproductive Medicine 51rst Annual Meeting 1995 Oct 7-12, 1995 1995.

55. Cohen B, Barad D. Design for resident education in reproductive endocrinology In: CREOG/APGO Orlando FL 1995 March 8-11, 1995 1995.

56. Zinger M, Zapantis G, Amin H, Cohen B, Witt B, Barg P, Barad D, Lindheim S. Implantation and pregnancy rates among recipients of different ages. In: 43rd Pacific Coast Fertility Society; 1995 April 26-30, 1995; 1995.

57. Zinger M, Zapantis G, Amin H, Cohen B, Witt B, Barg P, Barad D, Lindheim S. Pre and post-hCG progesterone are not predictive of pregnancy outcome in IVF-ET cycles In: 43rd Pacific Coast Fertility Society 1995 April 26-30, 1995 1995.

58. Goluboff E, Fisch H, Diamond B, Olson J, Bierbaum R, Feldshuh J, Broder S, Seaman E, Barad D, Olsson C. Semen analysis in 1283 men from the united states over a 25 year period. In: American Urology Society; 1996; 1996.

59. Kaali S, Barad D, Merkatz I. Comparison of the abdominal wall stability of Endopath Optiview with the standard laparoscopic trocar In: AAGL 25th Annual Meeting 1996 September 24-29, 1996 Chicago Ill 1996.

60. Kaali SG, Barad DH, Merkatz IR. Comparison of the Abdominal Wall Stability of Endopath Optiview with the Standard Laparoscopic Cannula. J Am Assoc Gynecol Laparosc 1996;3(4, Supplement):S19.

61. Lieman H, Robins J, Barad D. The use of a Urologic Stone Basket for Endometrial Polypectomy.

CV David Barad

In: American Society of Reproductive Medicine; 1997 October 16-18; Cincinatti, Ohio; 1997.

62. Bevalaqua K, Barad D, Youchah J, Witt B. Is affect Associated with infertility treatment outcome-. In: American Society for Reproductive Medicine 54th Annual Meeting; 1998 Oct 4-9, 1998; San Francisco, CA; 1998.

63. Barg PE, Barad DH, Witt BR, Amin HK. Availability of Cryopreservable Embryos of Good Quality Predicts Cycle Success and High Order Multiple Gestation. Fertility and Sterility 2000;74(3, Supplement 1):S151.

64. Bevilacqua K, Barad D, Youchah J, Witt B. Infertility Patients: Communication within Couples. Fertility and Sterility 2000;74(3, Supplement 1):S189.

65. Chervenak JL, Swigar M, Barad DH, Bevilacqua K, Lai YL, Santoro N. Reduced Cognitive Performance by Estradiol Is Reversed by Progesterone in Perimenopausal Women. Fertility and Sterility 2000;74(3, Supplement 1):S235-S6.

66. Pollack SE, Tang JJ, Barad DH. An Incompletely Resected, Obstructing Longitudinal Vaginal Septum Causing Copious Mucus Discharge. Fertility and Sterility 2000;74(3, Supplement 1):S14.

67. Pollack SE, Kovacs P, Chervenak JL, Lieman HJ, Barad DH, Witt BR. Screening Saline Hysterosonography Predicts Intrauterine Pathology in Women Undergoing In Vitro Fertilization. Fertility and Sterility 2000;74(3, Supplement 1):S235.

68. Bevilacqua K, Barad DH. Towards a behavioral picture of infertility patients. Fertility and Sterility 2001;76(3, Supplement 1):S198-S9.

69. Jindal SK, Gatzen C, Barad D. Use of gonadotropin releasing hormone (GnRH) antagonist vs agonist in repeat stimulation cycles of poor responders. Fertility and Sterility 2002;78(Supplement 1):S151.

70. Kovacs P, Pal L, Witt BR, Barad DH. Blastomere survival during cryopreservation is directly related to pregnancy rate following FET. Fertility and Sterility 2002;78(Supplement 1):S127.

71. Kovacs P, Pal L, Barad DH. Progesterone level on the day of HCG injection adversely affects blastomere survival during cryopreservation. Fertility and Sterility 2002;78(Supplement 1):S130-S1.

72. Goudas VT, Jindal SK, Chudnoff S, Witt BR, Barad DH, Santoro NF. Ovarian reserve and cycle number predict success of superovulation and intrauterine inseminations. Fertility and Sterility 2003;80(Supplement 3):156-7.

73. Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) Pre-Treatment and Ovulation Induction for In Vitro Fertilization among Women with a History of Decreased OvarianReserve: Fertility and Sterility: ASRM/CFAS 2005, American Society for ReproductiveMedicine, Montreal, Quebec, September 2005, Vol 84, Sup 1

CV David Barad

74. Barad D, Gleicher N: Effect of Race in Ovulation Induction, Oocyte Recovery, and Pregnancy Outcome in In-Vitro Fertilization: Fertility and Sterility: ASRM/CFAS 2005,American Society for Reproductive Medicine, Montreal, Quebec, September 2005, Vol84, Sup 1

75. Barad D, Weghofer A, Gleicher N: Evidence for an empiric definition of diminished ovarian reserve (DOR), resistance to stimulation and diagnosis of premature ovarian aging (POA), based on age-specific baseline. Fertil Steril 2006; 86:S125-6.93.

76. Gleicher N, Weghofer A, Barad D: Adrenal function in women with premature again ovaries. Fertil Steril 2006; 86:S401.

77. Weghofer A, Barad D, Gleicher N: Are women with premature ovarian aging (POA) at risk for chromosomally abnormal embryos? The association between embryonic aneuploidy rates and POA. Fertil Steril 2006; 86:S403-4.

78. Brill H, Barad D, Gleicher N: Dehydroepiandrosterone (DHEA) supplementation and pregnancy outcome: Effect on pregnancy rate and speed of conception. Fertil Steril 2006;86: S124-5.

79. Weghofer A, Barad D, Gleicher N: Premature Ovarian Aging (POA) is not characterized by an increase in aneuploidy rates. Hum Reprod Abstract Book 2006; 21: Supplement 1:i8.

80. Gleicher N, Barad D: The effect of dehydroepiandroserone on diminished ovarian reserve. Hum Reprod Abstract Book 2006; 21: Supplement 1: i69.

81. Weghofer A, Munne S, Chen S, Barad D, Gleicher N: Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007; 86:S462.

82. Singer T, Barad D, Gleicher N: A comparison of serum anti-mullerian hormone and cycle baseline follicle stimulating hormone in prediction of ivf outcomes. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

83. Barad D, Weghofer A, Gleicher N: Age-specific cut-offs for FSH assessment of ovarian function: improved diagnosis of premature ovarian aging (POA). American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

84. Gleicher N, Weghofer A, Barad D: Increased euploid embryos after supplementation with DHEA in women with premature ovarian aging. American Society for ReproductiveMedicine, 63rd Annual Meeting, Washington, D.C. 2007.

85. Gleicher N, Barad D: Does gender selection devalue women? American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

86. Weghofer A, Brill H, Barad D, Gleicher N: Does autoimmunity play a causative role in the pathophysiology of premature ovarian aging (POA)? American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

87. Gleicher N, Weghofer A, Li J-M, Barad D: Increased risk of POA in Chinese women. American

CV David Barad

Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C.2007.

88. Barad D, Gleicher N, Weghofer A, Chen S, Cohen J: Validation of age-specific cut-offs for ovarian function assessment by FSH levels via a second patient population: inherent differences in patient populations between IVF centers. American Society for Reproductive Medicine, 63rd Annual Meeting, Washington, D.C. 2007.

89. Gleicher N, Barad D: The impact of DHEA supplementation on IVF pregnancy rates in women ages 40-47 years. American Society for Reproductive Medicine, 63rd AnnualMeeting, Washington, D.C. 2007.

90. Barad D, Gleicher N: Implantation rate and pregnancy rates following all freeze cryopreservation cycles compared to those following cryopreservation of excessembryos. American Society for Reproductive Medicine, 63rd Annual Meeting,Washington, D.C. 2007.

91. Oktay K, Sahin G, Ucar F, Barad D, Blanchette H, Gleicher N: Fertility preservation is anemerging discipline extending beyond cancer patients: analysis of a large experience.”Fertil Steril 2008; 90(Supl): S51.

92. Oktay K, Oktem O, Barad D, Gleicher N: “Longevity of autologous ovarian transplants:extended experience in humans.” Fertil Steril 2008; 90(Supl): S53.

93. Gleicher N, Weghofer A, Oktay K, Barad D. “Relevance of low expansion CGG triplerepeat numbers on the FMR1 gene to functional ovarian reserve.” Fertil Steril 2008;90(Supl): S58.

94. Oktay K, Barad D, Gleicher N, Smotkin-Tangorra M. “Retrieval and cryopreservation of large number of oocytes from a 15 year old with primary amenorrhea and diagnosis of premature ovarian failure.” Fertil Steril 2008; 90(Supl): S91.

95. Gleicher N, Weghofer A, Oktay K, Barad D: “Autoimmune function and numbef or triple CGG expansions on the FMR1 gene as independent risk factors for premature ovarian senescence.” Fertil Steril 2008; 90(Supl): S151.

96. Oktay K, Kim JY, Barad D, Gleicher N, Blanchett H: “Serum FSH monitoring improves decision making in women undergoint controlled ovarian hyperstimulation with letrozoleand follicle stimulating hormone.” Fertil Steril 2008; 90(Supl): S183.

CV David Barad

97. Klein K, Stammler-Safar M, Krampl E, Gleicher N, Barad D, Weghofer A: “The impact of fetal sex on prematurity in dichorial-diamniotic twin pregnancies after assistedreproduction.” Fertil Steril 2008; 90(Supl): S209.

98. Barad DH, Weghofer A, Oktay K, Gleicher N: “Triple CGG expansions on the FMR1gene and response to ovarian stimulation.” Fertil Steril 2008; 90(Supl): S233.

99. Gleicher N, Ryan E, Weghofer A, Oktay K, Blanco-Mejia S, Barad DH:“Dehydroepiandrosterone (DHEA) reduces miscarriage rates in women with diminishedovarian reserve: a multicenter study.” Fertil Steril 2008; 90(Supl): S258-259.

100. Gleicher N, Weghofer A, Oktay K, Barad D: “The distribution of causative etiologies in infertile women with a diagnosis of spontaneous premature ovarian senescence, exclusiveof end-stage premature ovarian failure (POF).” Fertil Steril 2008; 90(Supl): S259.

101. Barad D, Oktay K, Weghofer A, Gleicher N: “Anti-Mullerian hormone (AMH), but not follicle stimulating hormone (FSH), correlates to oocyte yield in in vitro fertilization.”Fertil Steril 2008; 90(Supl): S259-260.

102. Goyal A, Barad DH, WEghofer A, Oktay K, Gleicher N. Predicting improvements in ovaian reserve and pregnancy rates after supplementation of dehydroepiandrosterone(DHEA) in diinihshed ovarian reserve. Hum Reprod 2009;24 (Suppl1):i79.

103. Barad DH, Weghofer A, Oktay K, Gleicher N. What are the effects of race/ethnicity on triple CGG counts on the FMR1 (fragile X) gene? Hum Reprod 2009;24(Suppl 1):i100.

104. Oktay K, Turkcuoglu I, Barad DH, Gleicher N, Kim JY. Prospective comparison of letrozole-FSH stimulation followed by hCG vs GnRH for fertility preservation in womenwith breast cancer. Hum Reprod 2009;24(Suppl 1):i119-i120.

105. Gleicher N, Weghofer A, Oktay K, Barad DH. A potential new function of the FMR1(fragile X) gene: Regulation of functional ovarian reserve. Hum Reprod2009;24(Suppl1):i97.

106. Gleicher N. Weghofer A, Barad DH. Triple CGG counts on the FMR1 (fragile X) gene vary between races/ethnicities based on distribution, but not based on normal range andmedian. Fertil Steril 2009;92(Suppl):S13.

107. Gleicher N, Goyal A, Weghofer A, Barad DH. Supplementation with dehydroepiandrosterone (DHEA) improves ovarian reserve, as reflected by anti-Müllerian hormone levels. Fertil Steril 2009;92(Suppl):S54-5.

108. Barad DH, Weghofer A, Goyal A, Gleicher N. Age-specific anti-Müllerian hormone (AMH) levels discriminate at each age between poorer and better oocytes yields. FertilSteril 2009;92(Suppl):S101.

109. Barad DH, Weghofer A, Goyal A, Gleicher N. Further refinement in defining the effect of heterozygous-abnormal CGG counts on the FMR1 (fragile X) gene: definition ofdistinct

CV David Barad

subgroup of PCOS patients, based on normal/low genotype. Fertil Steril2009;92 (Suppl):S105.

110. Gleicher N, Weghofer A, Barad DH. The FMR1 gene, a regulator of functional ovarian reserve over reproductive life times. Fertil Steril 2009;92 (S174-5).

111. Barad DH, Weghofer A, Goyal A, Gleicher N. What does discordance between folliclestimulating hormone (FSH) and anti-Müllerian hormone (AMH) mean? Fertil Steril2009;92(Suppl):S178.

112. Barad DH, Weghofer A, Gleicher N. How predictive of basic pregnancy potential are extremely low levels of anti-Müllerian hormone (AMH)? 65th Annual Meeting of the American Society for Reproductive Medicine, Atlanta, Georgia, October 17-21, 2009.

113. Weghofer A, Dietrich W, Ortner I, Barad DH, Biegelmayer C, Gleicher N. Age-specific anti-Mullerian hormone (AMH) in a fertile cohort: not as stable as previously thought. 26th Annual Meeting of ESHRE, Rome, Italy, June 27-30, 2010.

114. Barad D, Gupta A, Gleicher N. A slim PCOS-phenotype, characterized by heterozygousnormal/low genotype on the FMR1 (fragile X) gene. 26th Annual Meeting of ESHRE, Rome, Italy, June 27-30, 2010.

115. Gleicher N, Barad DH. A new concept of ovarian aging: oocytes remain perpetually "young"; it is the ovarian environment in which folliculogenesis occurs that ages. 26th Annual Meeting of ESHRE, Rome, Italy, June 27-30, 2010.

116. Lee I, Barad DH, Weghofer A, Gleicher N. New evidence as an explanation for the negative impact of autoimmunity on reproductive success in association with IVF. HumReprod 2011;26 (Suppl 1):i20-21.

117. Gleicher N, Weghofer A, Barad DH. The impact of ovarian FMR1 genotypes and subgenotypes in young oocyte donors on ovarian reserve and recipient pregnancy rates. HumReprod 2011;26 (Suppl 1):i72-73.

118. Vidali A, Barad DH, Gleicher N. Successful treatment with intrauterine perfusion of granulocyte colony stimulating factor (G-CSF) of chronically intractable thinendometrium. Hum Reprod 2011; 26 (Suppl 1):i222-223.

119. Gleicher N, Barad DH. Evidence based medicine (EBM): what’s next? Cannot replace clinical judgment. Proceedings of the 13th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI), Berlin, Germany, Nov. 4-7, 2010; Ben-Rafael Z ed, Monduzzi Editore 2010, p161-6.

120. Gleicher N, Weghofer A, Barad DH. Preimplantation genetic screening (PGS) is an experimental tool that should be banned from routine clinical use: PGS, as currently practiced, is associated with inferior results and should not be routinely offered. Idem; pp171-5.

121. Gleicher N, Weghofer A, Barad DH. Has anti-Müllerian hormone (AMH) become essential in

CV David Barad

assessing ovarian reserve? – NO. Idem; pp189-94.

122. Gleicher N, Weghofer A, Barad DH. Can diminished ovarian reserve be treated effectively? – YES. Idem; pp195-201.

123. Gleicher N, Shohat-Tal A, Lazzaroni E, Michaeli T, Lee HJ, Barad DH. Androgen dynamics in women with diminished functional ovarian reserve (DOR) after dehydroepiandrosterone (DHEA) supplementation. Fertil Steril 2012; 98 (Suppl 3):S201

124. Weghofer A, Kim A, Barad DH, Gleicher N. Increased recipient pregnancy rates are associated with CGGn on donors’ FMR1 genes. Fertil Steril 2012; 98 (Suppl 3): S269-S270.

125. Barad DH, Khanna P, Kushnir VA, Gleicher N. Clinical in vitro fertilization (IVF) outcomes based on comparative anti-Müllerian hormone (AMH) testing with a standard and new highly sensitive assay. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

126. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. The impact of advancing female age on gene expression of human granulosa cells. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

127. Vega M, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N. Low functional ovarian reserve (FOR) is in infertile women associated with presence of antiphospholipid antibodies. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

128. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. Proliferation and gene expression are affected by advancing female age in cultured human granulosa cells. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

129. Kushnir VA, Sen A, Hammes SR, Barad DH, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N. Proof of concept in a mouse model for beneficial effects of dehydroepiandrosterone (DHEA) on small growing follicles. Poster presentation at ICE/ENDO 2014, Chicago, Illinois, June 21-24. 2014.

130. Barad DH, Khanna P, Kushnir VA, Lazzaroni-Tealdi E, Wu Y-G, Lee H-J, Gleicher N. Differences in amh assessments between standard and new high sensitivity AMH assays and impact on prediction of ivf outcomes. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

131. Wu Y-G, Lee H-J, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Gleicher N. Effects of advancing female age on proliferation and gene expression in cultured human granulosa cells from post-hCG retrieved follicles. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

132. Wu Y-G, Lee HJ, Barad DH, Kushnir VA, Lazzaroni-Tealdi E, Sen A, Gleicher N. The effects of dehydroepiandrosterone (DHEA) on cultured human granulosa cells from postovulatory human follicles after in vitro fertilization (IVF). ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

133. Khanna P, Kushnir VA, Barad DH, Gleicher N. Live births rates following oocyte donation reflect

CV David Barad

performance of IVF centers in autologous IVF cycles. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

134. Kushnir VA, Khanna P, Barad DH, Gleicher N. Assesment of practice in IVF clinics in which success in autologous and donor oocyte cyles do not correlate. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

135. Kushnir VA, Wu Y-G, Chen I-C, Lee H-J, Barad DH, Lazzaroni-Tealdi E, Gleicher N. Mitochondrial DNA abundance declines in human cumulus granulosa cells with age. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

136. Lee H-J, Wu Y-G, Lazzaroni-Tealdi E, Barad DH, Kushnir VA, Gleicher N. Aging is associated with differential gene expression in human granulosa and cumulus cells leading to rapid progression of meiotic and oocyte maturation competence. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

137. Vega M, Barad DH, Weghofer A, Kushnir VA, Gleicher N. Evidence that a degree of mucosal inflammation is beneficial for pregnancy success in association with IVF. ASRM 2014, Honolulu, Hawaii, October 18-22, 2014.

138. Barad D. H., Weghofer A, Latham G.J., Filipovic-Sadic S, Kushnir V.A., Gleicher N. Significant skews in methylation fractions in previously described genotypes and sub-genotypes of the FMR1 gene. ESHRE Annual Meeting, Lisbon, Portugal, June 14-17, 2015

139. Vega M, Barad, D.H., Seier K, Yu Y, Kushnir V.A., Lazzaroni-Tealdi E, Wu Y-G, Wand Q, Weghofer A, Albertini D.F., Gleicher N. Immunologic and inflammatory markers in prediction models of clinical pregnancy and live birth in association with in vitro. ESHRE Annual Meeting, Lisbon, Portugal, June 14-17, 2015

140. Weghofer A, Kushnir V.A., Barad D. H., Gleicher N. The impact of thyroid stimulating hormone (TSH) on anti Mullerian hormone (AMH) levels in infertile women. Does TSH affect follicular recruitment? ESHRE Annual Meeting, Lisbon, Portugal, June 14-17, 2015

141. Bisplinghoff E., Barad D. H., Weghofer A, Kushnir V.A., Gleicher N. Comparison of FMR1 mutations distribution between Indian and other Asian patients. ESHRE Annual Meeting, Lisbon, Portugal, June 14-17, 2015

142. Gleicher N, Vidali A, Braverman J, Kushnir V.A, Barad D.H, Albertini D. F. Further Evidence Against Use of PGS in Poor Prognosis Patients: Reports of Normal Births After Transfer of Embroys Reported As Aneupoid. ASRM Annual Meeting, Baltimore, USA, Oct. 17-21, 2015.

143. Kushnir VA, et al. Proof of concept in a mouse model for beneficial effects of dehydroepiandrosterone (DHEA) on small growing follicles. Endocrine Society Meeting (ENDO 2016), Boston, MA, April 1- 4, 2016.

144. Bisplinghoff E, et al. Comparison of FMR1 mutations distribution between Indian and other

CV David Barad

Asian patients. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.

145. Wang Q, et al. Reduced mRNA levels and isoforms of the FMR1 gene in infertile women with low CGGnn<26 repeats. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.

146. Kushnir VA, et al. World trends in assisted reproductive technology (ART) 2004-2013. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.

147. Barad DH, et al. Association of skewed X-Chromosome inactivation with FMR1 CGG repeat length and AMH levels as indictor of functional ovarian reserve in infertile women. ESHRE Meeting, Helsinki, Finland, July 3-6, 2016.

148. Wu YG et al. What is the best lead follicle size for ovulation induction in older women ≥43 years to avoid premature luteinization of follicles? 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

149. Kushnir VA et al. Effects of newly introduced practices over 10 years (2004-2013) on worldwide trends in assisted reproductive technology. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

150. Kushnir VA et al. Utilization and effects of embryo banking on art outcome reporting in the U.S. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

151. Barad DH et al. Prevalence and effect of preimplantation genetic screening (PGS) on oocyte donation cycles in the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

152. Kushnir VA et al. Contribution of third party reproduction to the birth cohort following art in the U.S.A. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

153. Barad DH et al. Contribution of cryopreservation cycles to cumulative live birth outcomes following oocyte donation with preimplantation genetic screening (PGS) in the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

154. Shapiro AJ et al. Racial and ethnic disparities in the use of third-party art in the U.S. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

155. Shapiro AJ et al. Effect of race and ethnicity on live birth rates in third-party art cycles in the U.S. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

156. Kushnir VA et al. Effect of race and ethnicity on fertility rates and utilization of art in the USA. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT,

CV David Barad

October 15-19, 2016.

157. Barad DH et al. Effect of time trends of preimplantation genetic screening (PGS) utilization on oocyte donation cycle live birth rates in the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

158. Gleicher N et al. Preimplantation genetic screening (PGS) appears unable to correctly determine ploidy of embryos from a single trophectoderm biopsy (TEB). 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016.

159. Barad DH et al. Effect of PGS on IVF outcomes following eSET in oocyte donation in the United States: 2005 to 2013. 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October 15-19, 2016. Albertini DF, et al. Ontogeny of newly described hypo-androgenic PCOS phenotype in infertile women from younger through older ages. Hum Reprod 2017;32(Supp1):i447.

160. Barad DH, et al. Prevalence and impact of elective gender selection in oocyte donor recipient cycles in the United States 2005-2013. Hum Reprod 2017;32(Supp1):i481.

161. Barad DH, Kushnir VA, Albertini DF, Darmon SK, Gleicher N. Does gender selection in donor-recipient cycles affect IVF cycle outcomes? Fertil Steril 2017;108(3):e342-343.

162. Kushnir VA, Choi J, Darmon SK, Albertini DF, Barad DH, Gleicher N. CDC reported assisted reproductive technology (art) live birth rates are misleading to the public. Fertil Steril 2017;108(3):e333.

163. Gleicher N, Barad DH, Darmon SK, Kushnir VA. Declining birth rates from IVF over the last decade due to commoditization and industrialization. Fertil Steril 2017;108(3):e344.

164. Gleicher N, Barad DH, Darmon SK, Kushnir VA. Deterioration of inherent treatment prognosis of infertility patients over the last 5 years (2012-2016). Fertil Steril 2017;108(3):e344-345.

165. Shapiro A, Darmon SK, Barad DH, Gleicher N, Kushnir VA. Do serum vitamin d and anti-mullerian hormone levels correlate in reproductive-age women? Fertil Steril 2017;108(3):e219-220.

166. Wang Q, Kushnir VA, Darmon SK, Barad DH, Wu Y-G, Zhang L, Albertini DF, Gleicher N. Reduced mRNA levels of the FMR1 gene and changes of gene expression of cyp19 and FSHR in infertile women with low (CGGn < 26) repeats. Fertil Steril 2017;108(3):e143.

167. Weghofer A, Kushnir VA, Darmon SK, Hu J, Lazzaroni-Tealdi E, Zhang L, Albertini DF, Barad DH, Gleicher N. Oocyte size and morphology predict embryo quality. Fertil Steril 2018;110(4):e309-e310.

168. Weghofer A, Kushnir VA, Darmon SK, Hu J, Lazzaroni-Tealdi E, Zhang L, Albertini DF, Barad DH, Gleicher N. Association between characteristics of infertile patients and oocyte measurements. Fertil Steril 2018;110(4): e310.

CV David Barad

169. Kushnir VA, Hu J, Barad DH, Weghofer A, Gleicher N. Sexual function in older premenopausal infertile women does not correlate with patient demographics and endocrine parameters. Fertil Steril 2018;110(4): e157.

170. Weghofer A, Darmon SK, Kushnir VA, Albertini DF, Barad DH, Gleicher N. The ovarian sensitivity index (OSI) predicts embryo quality in oocyte donors. Fertil Steril 2018;110(4): e317.

171. Weghofer A, Darmon SK, Kushnir VA, Gleicher N, Barad DH. Euploid miscarriage is associated with elevated serum C-reactive protein levels in infertile women. Fertil Steril 2018;110(4): e129-e130.

CV David Barad

Letters:

1. Barad D, Feinman M. GnRH Agonists and IVF--controls?[comment]. Fertility & Sterility;52:518-9, 1989.

2. Barad DH. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization. Obstet Gynecol;106:196-7; author reply 7, 2005.

3. Gass M, Anderson GL, Barad D. Concerns about published data from the estrogen-progestin (HT) arm of the WHI. Am J Obstet Gynecol;192:333; author reply 4, 2005.

4. Gleicher N, Barad DH. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study. Hum Reprod;21:3027; author reply -8, 2006.

5. Prentice RL, Stefanick ML, Howard BV, Barad D, Kuller L. FIVE AUTHORS REPLY. Am J Epidemiol;163:1068-9, 2006.

6. Gleicher N, Barad D. DHEA and testosterone in the elderly. N Engl J Med 2007; 356:636-7; author reply 7.

7. Gleicher N, Barad DH. Mild versus standard in-vitro fertilisation techniques. Lancet 2007;369:1855; author reply -6.

8. Gleicher N, Barad DH. Androgen priming before ovarian stimulation for IVF. Hum Reprod;23:2868-70; author reply 70-1, 2008.

9. Barad DH, Gleicher N. Less may, indeed, be less: multicollinearity in studies of ovarian reserve. Fertil Steril;91:e16; author reply e7-8, 2009.

10. Barad DH, Weghofer A, Gleicher N. Dehydroepiandrosterone treatment of ovarian failure. Fertil Steril;91:e14; author reply e5, 2009.

11. Gleicher NN, Weghofer A, Barad DH. Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response. Hum Reprod;27:2241-2; author reply 2-3, 2012.

12. Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening is alive and very well: really? Fertil Steril;100:e36, 2013.

13. Kushnir VA, Barad DH, Gleicher N, Vidali A. Reply of the authors. Fertil Steril;100:e26, 2013.

14. Kushnir VA, Vidali A, Barad DH, Gleicher N. Reply of the authors. Fertil Steril;100:e18, 2013.

15. Gleicher N, Barad DH, Kushnir VA, Sen A, Weghofer A. Poor responders and androgen ajuvant treatment: “Still haven’t found what I’m looking for...” Reprod Biomed Online 2014; In press.

CV David Barad

Biography

Dr. Barad is an Associate Clinical Professor with joint appointment in the departments of Epidemiology and Social Medicine and Obstetrics and Gynecology at the Albert Einstein College of Medicine. From July 1984 until April 2001, Dr. Barad, MD served on the full time faculty of the Albert Einstein College of Medicine, where he was an Associate Professor in the Department of Obstetrics and Gynecology & Women’s Health. He also served as the Director of the Division of Reproductive Endocrinology in the Department of Obstetrics and Gynecology at the Montefiore Medical Center. He is a 1972 graduate of Rutgers College and a 1978 graduate of Rutgers Medical School (now known as Robert Wood Johnson Medical School). Dr. Barad completed his residency in Obstetrics and Gynecology at Columbia Presbyterian Medical Center in 1982. Dr. Barad went on to sub-specialty training in the Reproductive Endocrinology Fellowship at the Brigham and Women’s Hospital of Harvard Medical School. He finished his fellowship at Harvard in 1984. In 2003 Dr. Barad received a Masters of Science in the Clinical Research Training Program at the Albert Einstein College of Medicine. Dr. Barad is a Co-investigator in the Women’s Health Initiative and is Chair of the WHI Hormone Advisory Committee. The WHI is the largest and longest clinical trial of both diet and hormone replacement therapy ever conducted. Dr. Barad’s research covers a broad range of interests including postmenopausal hormone treatment, osteoporosis, and postmenopausal symptoms as well as ovarian function, ovulation induction and in vitro fertilization. Dr. Barad presently practices in Manhattan at the Center for Human Reproduction, where he is Director of Assisted Reproductive Technology. Dr. Barad is on the Voluntary Staff of St Luke’s Roosevelt Hosptial as an Associate Attending in the Depart of Obstetrics and Gynecology.

Dr. Barad has published extensively in the field of reproductive endocrinology and has achieved a national and international reputation in that discipline. He is the recipient of the 1996 Kokopelli Ball Resolve of New York City Chapter Award for “outstanding dedication and commitment to family building”.

name: david h. barad, md, ms - center for human ...community hosp at dobbs ferry 128 ashford ave...

Documents